5 options
Journal for immunotherapy of cancer.
BioMed Central Journals Complete Available from 12/01/2013 volume: 1 issue: 1 until 12/31/2019 volume: 7 issue: 1. Available online
View onlineGale Academic OneFile Available from 05/29/2013 volume: 1 until 12/31/2019 volume: 7 issue: 1. Available online
View onlineSpringer Nature OA Free Journals Available from 12/01/2013 volume: 1 issue: 1 until 12/31/2019 volume: 7 issue: 1. Available online
View online- Format:
- Journal/Periodical
- Language:
- English
- Subjects (All):
- Cancer--Immunotherapy--Periodicals.
- Cancer.
- Cancer--Immunological aspects--Periodicals.
- Tumors--Immunological aspects--Periodicals.
- Tumors.
- Immunotherapy--Periodicals.
- Immunotherapy.
- Neoplasms--immunology.
- Neoplasms--therapy.
- Cancer--Immunological aspects.
- Cancer--Immunotherapy.
- Tumors--Immunological aspects.
- Medical Subjects:
- Immunotherapy.
- Neoplasms--immunology.
- Neoplasms--therapy.
- Genre:
- Fulltext.
- Internet Resources.
- Periodicals.
- Physical Description:
- 1 online resource
- Irregular
- Began with Volume 1 (2013).
- Other Title:
- JITC
- Place of Publication:
- London : BioMed Central, 2013-
- London, United Kingdom : BMJ Publishing Group Ltd.
- System Details:
- Mode of access: World Wide Web.
- Summary:
- "Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications."
- Notes:
- Refereed/Peer-reviewed
- Description based on: Volume 1 (2013); title from homepage (publisher's website, viewed June 5, 2013).
- Latest issue consulted: Volume 5 (2017) (Biomed Central website, viewed August 9, 2017).
- ISSN:
- 2051-1426
- OCLC:
- 846867215
- Access Restriction:
- Unrestricted online access
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.